Thioredoxin Systems
Latest round
- Series A
Last raised
- Oct 2024
Total raised
- $2.4M
Investors
- 4
About Thioredoxin Systems
Founded in 1994 by founder Arne Holmgren and based in Stockholm, Sweden, Thioredoxin Systems AB develops antibiotics for treating multidrug-resistant infections. The company’s flagship product, EbsArgent, is an antibiotic regimen for addressing complicated urinary tract infections (cUTIs) caused by antibiotic-resistant bacteria. The product employs a mechanism of action that disrupts bacterial antioxidant redox systems against a broad spectrum of pathogens.
Who invested in Thioredoxin Systems
4 investors across 1 round
See all investors in Thioredoxin Systems
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 30, 2024
Amount
$2.4M
Investors
Questions about Thioredoxin Systems
Who invested in Thioredoxin Systems?
Thioredoxin Systems has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Thioredoxin Systems raised?
Thioredoxin Systems has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Thioredoxin Systems last raise money?
Thioredoxin Systems's most recent round on record is a Series A, in Oct 2024.
What does Thioredoxin Systems do?
Founded in 1994 by founder Arne Holmgren and based in Stockholm, Sweden, Thioredoxin Systems AB develops antibiotics for treating multidrug-resistant infections.
Where is Thioredoxin Systems headquartered?
Thioredoxin Systems is headquartered in Stockholm, Sweden.
Which VCs invest in companies like Thioredoxin Systems?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Thioredoxin Systems's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Thioredoxin Systems? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.